These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17606205)

  • 41. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004.
    Flodén A; Castedal M; Friman S; Olausson M; Backman L
    Transplant Proc; 2007 Mar; 39(2):385-6. PubMed ID: 17362737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organ allocation for liver-intestine candidates.
    Horslen S
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S86-9. PubMed ID: 15382223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does MELD work for relisted candidates?
    Edwards E; Harper A
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S10-6. PubMed ID: 15382287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should liver transplantation in patients with model for end-stage liver disease scores Perkins JD; Halldorson JB; Bakthavatsalam R; Fix OK; Carithers RL; Reyes JD
    Liver Transpl; 2009 Feb; 15(2):242-54. PubMed ID: 19177441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
    Moonka D; Castillo E; Kumer S; Abouljoud M; Divine G; Pelletier S
    Transplant Proc; 2009; 41(1):216-8. PubMed ID: 19249517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ; Chen HA; Lu MQ; Chen GH
    Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN; Perkins JD; Carithers RL
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on liver transplantation: indications, organ allocation, and long-term care.
    Lopez PM; Martin P
    Mt Sinai J Med; 2006 Dec; 73(8):1056-66. PubMed ID: 17285195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Split-liver transplantation in the high-MELD adult patient: are we being too cautious?
    Nadalin S; Schaffer R; Fruehauf N
    Transpl Int; 2009 Jul; 22(7):702-6. PubMed ID: 19254241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver transplantation in Hawaii.
    Wong LL; Cheung AH; Limm WM; Tsai NC
    Hawaii Med J; 1994 Mar; 53(3):86-9. PubMed ID: 8005783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
    Darwish Murad S; Kim WR; de Groen PC; Kamath PS; Malinchoc M; Valla DC; Janssen HL
    Liver Transpl; 2007 Jun; 13(6):867-74. PubMed ID: 17539007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MELD is not enough--enough of MELD?
    Cholongitas E; Senzolo M; Triantos C; Samonakis D; Patch D; Burroughs AK
    J Hepatol; 2005 Apr; 42(4):475-7; author reply 478-9. PubMed ID: 15763330
    [No Abstract]   [Full Text] [Related]  

  • 56. Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation?
    Huo SC; Huo TI; Lin HC; Chi CW; Lee PC; Tseng FW; Lee SD
    Transplantation; 2007 Dec; 84(11):1406-12. PubMed ID: 18091516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variation of the MELD score as a predictor of death on the waiting list for liver transplantation.
    Gheorghe L; Iacob S; Iacob R; Gheorghe C; Popescu I
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):267-72. PubMed ID: 17925920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
    Yu JW; Sun LJ; Zhao YH; Li SC
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1242-9. PubMed ID: 18637053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card.
    Freeman RB
    Hepatology; 2008 Mar; 47(3):1052-7. PubMed ID: 18161047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.